Procter & Gamble Health Q4 Results
- BSE: 500126
- NSE: PGHL
- ISIN: INE199A01012
- Sector: Biotechnology & Drugs
BSE
5,300
27.00 (0.51%)
27.00 (0.51%)Volume320.00
Updated: Wed 14 Oct, 2026 | 15:29:50
NSE
5,237.50
-58.00 (-1.10%)
-58.00 (-1.10%)Volume14.03 K
Updated: Wed 14 Oct, 2026 | 15:29:55
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - Procter & Gamble Health Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 241.03 | 269.30 | -10.50% | 262.98 | 2.37% |
| Depreciation/ Amortization | 6.17 | 5.90 | 4.58% | 7.16 | 14.90% |
| Operating Income | 129.42 | 104.56 | 23.78% | 20.90 | 71.30% |
| Net Income | 94.60 | 77.59 | 21.92% | 16.78 | 54.63% |
| Other Operating Expenses Total | 91.13 | 91.77 | -0.70% | 107.83 | 10.38% |
| Net Income Before Taxes | 133.21 | 108.82 | 22.41% | 22.83 | 69.63% |
| Total Revenue | 370.45 | 373.86 | -0.91% | 283.88 | 19.12% |
| Selling/ General/ Admin Expenses Total | 50.86 | 61.81 | -17.72% | 48.63 | 4.24% |
| Diluted Normalized EPS | 56.99 | 46.74 | 21.93% | 19.03 | 55.34% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.